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(blue baby syndrome) and cancer (via formation of nitrosamines).
Over the years, the fear of nitrate flourished, despite lack of
evidence for a carcinogenic effect in humans. Recent research has
found that nitrate and its metabolite nitrite may possess some
beneficial properties (14,15) and it seems as we a facing somewhat
of a paradigm shift.
Comparative studies in germfree and conventional animals have
clearly shown that the gastrointestinal microbiota play a substan-
tial role in the nitrogen metabolism of the host (16,17,18). When
ingested, nitrate is rapidly absorbed and actively excreted into
saliva. Oral microorganisms will rapidly convert nitrate to nitrite
and further to nitric oxide, both compounds are known to inhibit
some bacteria and yeast  and to be utilized by others. If reaching
the stomach, nitrite is non-enzymatically converted to nitric oxide
under acidic conditions. It is well known that mammals produce
nitric oxide in various cells, but the substrate is arginine and not
nitrate. Nitric oxide is one of the most reactive molecule to be
found in the mammalian body and is accepted to be a biological
messenger of key importance. Obviously, the microorganisms in
the digestive tract play a major role in nitrate metabolism. The
difference in nitric oxide concentration in the stomach of
conventional rats are significantly higher (up to 3 logs difference)
in conventional than in germfree rats (17), Additionally, intestinal
concentration of nitric oxide can be increased by giving nitrite to
the animal (17). Some probiotic bacteria can convert nitrite
to nitric oxide whereas other bacteria., as staphylocci, may be able
to utilize formed nitric oxide. The biological significance of the
microbial influence on ingested nitrate and nitrite is not fully
understood. The key point is that some microbes convert nitrate
to a compound that may act upon the host as well as upon other
parts of the microbiotia.
Creatinine is usually regarded as an end product since no
mechanism is known whereby creatinine can be degraded in
mammalian tissue and it is excreted to feces and urine. However,
it is puzzling that methylguanidine, a metabolite deriving from
breakdown of creatinine is found in urine of germfree rats (13). If
this old observation can be substantiated, it might be wise taking a
new look on creatinine metabolism.; i.e. it might not be an end
product.
Conclusion: The main lesson from several comparative studies in
germfree and conventional animals is the gastrointestinal micro-
biota is receiving nitrogen from the host, but the net outcome is
that the microorganism are helping the host in saving nitrogen.
Thus, host-microbial interactions shape the nutrient environment
of the mammalian gastrointestinal tract. It is a win-win situation
for both parts. Germfree animals need substantial more nitrogen
in their diet than their conventional counterparts.
Given the same amount of food, ex-germfree animals will gain
weight when they are conventionalized. Alterations in recycling of
nitrogen might account for some of this increase in weight.
References
1. Hooper LV, Midtvedt T, Gordon JI. How host-microbial
interactions shape the nutrient environment of the mammalian
intestine ANN REV NUTR 2002;22:283307.
2. Wu G. Urea synthesis in enterocytes of developing pigs.
Biocjem J 1995;312:717723.
3. Mousa HM, Ali KE, Hume ID. Effects of water deprivation on
urea metabolism in camels, desert sheep and desert goats fed dry
desert grass. Comp. Biol. Physiol A. 1983;74:715720.
4. Leng L, Boda K, Tasenov KT, Karinbaev RS, Makasev EK,
Rachimberdiev SA, Tiegenov DG, Jurgalieva LA. Renal regula-
tion of the excretion of urea in fasting camels. Vet Med (Ptaha)
1984;29:539547. 4.
5. Levenson SM, Crowley DV, Horowitz RE, Malm OJ. The
metabolism of carbon-labelled urea in the germ-free rat. J Biol
Chem 1959;234:20612062.
6. Mead GC. Microbes of the avian cecum: types present and
substrates utilized. J Exp Zool 1989;3:4854.
7. Chadwick VS, Jones JD, Debongnie JC, Gainella T. Phillips SF.
Urea, uric acid and creatinine fluxes through the small intestine of
man. Gut 1977;18:A944.
8. Falk PG, Hooper LV, Midtvedt T, Gordon JI. Creating and
maintaining the gastrointestinal ecosystem: what we know and
need to know from gnotobiology. Microbiol Mol Biol Rev
1998;62:11571170.
9. Vogels DG, van der Drift C. Degradations of purines and
pyrimidines by microorganissm. Bact Rev 1976;1076;40:403
468. 9
10. Durre P, Andreesen JR. Purines and glycine metabolism by
purinolytic bacteria. J Bacteriol 193;154:192199.
11. O’loughlin JA, Bruder JM, Lysaght MJ. In vivo and in vitro
degradation of urea and uric acid by encapsulated genetically
modified microorganisms Tissue Eng 2004:10:14461450.
12. Ducluzeau R, Raiboud P, Dickinson A, Sacquet E, Mocquet
G. Hydrolyse de l’uree in vitro and in vivo, dans la caecum de rat
gnotobiotques, par differentes souches bacteriennes isolees du
tube digestif de rats conventionnels. CF.R.Hebd Seances Acaid
Sci Series D 1966:266:944947.
13. Warren KS, Newton WL, Portal and peripheral blood
ammonia concentrations in germ-free and conventional guinea
pigs. Am J Physiol 1959;196:717720.
14. Archer DL. Evidence that ingested nitrate and nitrite are
beneficial to health. J Food Prot 2002;65:872875.
15. Lundberg JO, Feelisch M, Janssson Ea, Bjorne H, Weitsberg
E. Cardioprotective effects of vegetables: is nitrate the answer? N0
Biol Chem 2006:13:125130.
16. Persson MG, Midtvedt T, Leone Am, Gustafsson LE.
Ca(2/)-dependent and Ca(2/)-independent exhaled nitric oxide
presence in germ-free animals, and inhibition by arginine analo-
gues. Eur J Pharmacol 1994;264:1320.
17. Sobko T, Reinders C, Norin E, Midtvedt T, Gustafsson LE,
Lundberg JO. Gastrointestinal nitric axide generation in germ-free
and conventional rats. Am J Physiol Gastroenterol Liver Physiol
2004:993997.
18. Sobko T, Huang L, Midtvedt T, Norin E, Gustafsson LE,
Norman M, Jansson EA, Lundberg JO. Generation of NO by
probiotic bacteria in the gastrointestinal tract. Free Radic Biol
Med 2006;41:985991. 19.
19. Perez G, Faluotico R, Creeatinine: a precursor of methylua-
nidine. Experientia. 1973:29:14731474.
Lecture 2.1.3
Influence of the microflora on gastrointestinal nitric oxide
(NO) generation: studies in newborn infants and germ-free
animals
Tanja Sobko
Department of Physiology and Pharmacology, Karolinska Insti-
tutet, Stockholm, Sweden
The intestinal flora can elicit a number of effects in the gut,
however the mechanisms behind this are not entirely understood
(1). The communication between bacteria and the host occurs via
receptors and through the secretion of chemical mediators. The
studies presented here suggest that several common intestinal
bacteria can generate nitric oxide (NO), a potent biological
messenger with a variety of known physiological functions. NO
controls almost a limitless range of functions in the body and is
well accepted as biological messenger of key importance, involved
in the regulation of regional blood flow, respiration, gut motility,
water and electrolyte transport and immunity (2). In mammalian
cells NO is synthesized from the amino acid L-arginine and
molecular oxygen by nitric oxide synthases (NOS). NO is also
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formed in the human body by reduction of nitrite (NO2/0/NO),
as first described in the stomach. Denitrifying bacteria in soil
generate NO from nitrate (NO3/) and nitrite (NO2/) as a part
of the nitrogen cycle and the impact of bacteria and nitrite on
human health has been suggested (3). The main focus of the
studies described below has been to investigate whether the micro-
organisms residing in the gastrointestinal (GI) tract could
contribute to endogenous NO generation and under which
conditions this would occur in vivo.
We developed several new unique methods to directly measure
gaseous NO in vivo in the colon of newborn infants and in the
entire GI tract of conventional and germ-free animals. In addition,
we investigated NO generation and consumption by different gut
bacteria by measuring gaseous NO under aerobic and anaerobic
conditions.
First we monitored the initial bacterial colonization in newborn
infants born vaginally or via Caesarian secton following the
intracolonic hydrogen gas (H2), faecal short-chain fatty acids
(SCFA) and NO (4). All these markers were virtually undetectable
at birth but increased in a particular pattern-bacterial products
(H2 and SCFA) appeared first followed by NO some days later.
Interestingly, in some apparently healthy infants, colonic NO
levels increased to levels similar to those seen in adults with
inflammatory bowel disease, indicating a vivid activation of the
immune system in response to the emerging bacterial flora.
Since the infant gut is exposed to a myriad of colonizing bacteria
directly after birth5, we speculated that bacteria themselves could
contribute to the colonic NO generation in addition to the
mucosa. Our experiments showed that in conventional rats, NO
levels were distinctly compartmentalized with very high levels in
the stomach, intermediate levels in the caecum and lower levels in
the small intestine and colon. In contrast, in germ-free rats, NO
gas was low throughout the gastrointestinal tract. When we fed
rats nitrate, gastric NO increased greatly in conventional but not
in germ-free animals, thereby confirming nitrate to be a substrate
for bacterial NO generation (6).
The effects and mechanisms of action of probiotics are far from
being understood (7). We suggested and went on to demonstrate
that lactic acid producing bacteria can generate considerable
amounts of NO from nitrite in vitro (8). Reduction of nitrite to
NO was likely non-enzymatic, caused by bacterial generation of
acid. In the same study we measured in vitro gaseous NO
generation from human faeces. Mixed faecal flora generated NO
not only from nitrite but also from nitrate without a concomitant
drop in pH, which suggested pathways other than acidification of
nitrite. We demonstrated that intestinal NO generation can be
stimulated in rats by dietary supplementation with nitrate and
lactobacilli. Furthermore, in vitro studies showed that the
generation of NO by some probiotic bacteria might be counter-
acted by rapid NO consumption by other strains (E. coli and S.
aureus ). We also studied if nitrite/nitrate in breast milk would
interact with NO generation during the first days after birth and
found a correlation between the colonic NO levels and nitrite in
breast milk and in faeces of newborns (9).
Does luminal NO originates from the mucosa or is generated by
bacteria? This information might be important, since an induced
mucosal NO synthesis by NOS’s would signal a possible inflam-
matory reaction. It seems to be equally important to know if NO
can be generated by bacteria themselves as this could have a
physiological impact on the host. In principle, there are two ways
in which bacteria could contribute to intestinal NO production:
bacteria stimulate cells in the mucosa to produce NO and that
bacteria produce NO themselves. Judging from our studies, both
mechanisms are possible but they seem to operate at different
locations.
The newborn infant seem to be exposed to considerable levels of
nitrite and nitrate during the first weeks of life as the physiological
levels in the breast milk are highest immediately after birth and
progressively decline with time. The establishing micro-flora may
directly utilize the breast milk nitrate, converting it from an inert
stable anion that the human cells cannot use into the more reactive
nitrite. This nitrite could be toxic, but if further converted into
nitric oxide, it might have possible beneficial physiological effects
(10). In this way, increased amounts of nitrate in breast milk might
be important for the regulation of bacterial establishment as well
as for the donation of nitrogen to the GI tract. The need of
nitrogen is known to be higher in newborn infants, as they use it
for synthesis of proteins, enzymes etc(11). Bacteria use nitrogen in
the large intestine for de novo synthesis of amino acids (12), which
might be absorbed by the host, but this ability is lost progressively
with age. Since the nitrate/nitrite levels in breast milk vary with
age, influencing probably the NO generation as well as the
nitrogen balance in newborn infant, this should be taken into
account when the infant formulas with constant nitrate/nitrite are
introduced.
A fundamental remaining issue relates to the role of the bacterial
NO generated in the gut. NO is an extremely potent messenger
that regulates vital physiological processes in the pico-/nano molar
range (13). Thus, even minute production of this gas by gut
bacteria could be of biological significance. Judging from the
known biological properties of NO, it is not unreasonable that
some of the positive effects attributed to probiotics can be
explained by formation of NO by these bacteria as has been
suggested. NO and other nitrogen oxides generated by lactobacilli
from nitrite could help to prevent the establishment of pathogenic
bacteria in the gut. Indeed, these reactive nitrogen oxides are
highly toxic to many bacteria, including GI pathogens such as
Salmonella, Candida, Shigella, Yersinia and E. coli (14).
We conclude that bacteria residing in the GI tract can be a
significant alternative source of NO in the gut in addition to the
NO produced in the mucosa. NO generation by gut bacteria differ
profoundly from classical mammalian synthesis via NO synthases
as bacteria use nitrate and nitrite as substrates instead of L-
arginine. Intestinal NO generation can be stimulated by dietary
supplementation with substrate and lactobacilli. The NO genera-
tion by certain probiotic bacteria can be counteracted with rapid
NO consumption by other strains. Future studies will clarify the
biological role of the bacteria-derived intestinal NO in health and
disease and if an imbalance in generation vs consumption has any
significance in the patho-physiology of intestinal disorders. Newly
developed unique, minimally-invasive direct measurements of
intestinal gases may also be useful to study the dynamics of the
microbial colonization process and host-microbial interactions
early in life.
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Lecture 2.1.4
Experimental substantiation of new approaches to intest-
inal microbial ecology correction by means of probiotics
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Introduction: Normal symbiotic microflora is considered as an
integral part of the host. In the adult humans the normal
microflora is estimated to exceed the total number of mammalian
cells by at least an order of magnitude. More than 99% of the
commensal gastrointestinal bacteria are obligate anaerobes and
belong to 5001000 species (1). The microflora of the host
markedly contributes to the anatomy, physiology and metabolism
of man and animal (morphokinetic action, regulation of bacterial
and eukaryotic cell-to cell signalling, replication and phenotypic
expression of procaryotic and eukariotic genes, apoptosis, angio-
genesis, behaviour reactions, biorhythms, participation in meta-
bolism of proteins, carbohydrates, lipids, nucleic acids and other
substances, recirculation of bile acids, steroid hormones and other
macromolecules, oxidative/antioxidative reactions, etiology and
pathogenesis of many infectious and somatic diseases, processing
of foods, production of biologically and pharmacologically active
compounds, provision of colonization resistance, immune func-
tions, detoxication of exogenic and endogenic compounds and
metabolites and so on) (2, 3). Various physical, chemical,
biological agents, psycho-social and other stress factors can
produce dysbalance of host microflora resulting in different
disorders in above mention physiological functions, biochemical
and behaviour reactions.
For the last 3040 years several generations of probiotics contain-
ing living gomo- and geteroprobiotic microorganisms (bifidobac-
teria, lactobacilli, enterococci and others) have been worked out
and introduced in practical medicine for correction of micro-
ecological disorders in humans and animals. Now-days vast
majority of probiotics introduced in medical practice are used
for prophylaxis and treatment of infectious diseases caused by
pathogenic and opportunistic bacteria and viruses through in-
creasing host colonization resistance, improving immunity, sup-
pressing of microorganism growth and development. As usual
probiotic strains used for manufacture of probiotic food additives
or probiotic functional foods have been selected on the base of
their strong antagonistic activities against disease causative micro-
organisms. The ability of such probiotic strains interferes into
multiple other host physiological and metabolic functions and
reactions and possibility of their interactions with other gut
symbiotic microbe inhabitants as role have not taken into
consideration. Unfortunately the data have appeared that positive
effect of probiotics is usually temporary or may be completely
absent even in long-term applications. There is information that
even lactic acid bacteria can produce host microflora dysbalance
or can produce sometimes opportunistic infections (3,4).
Aim: One of the main reasons of probiotic ineffectiveness and
appearance of aside effects may be the incompatibility of probiotic
bacterial strains with the host resident microbiota. On lactoba-
cillus model the authors of this report experimentally substantiate
the necessity attached to selection of probiotics to take into
consideration the species, individual and anatomical biocompat-
ibility of probiotic lactobacillus strains with the indigenous
lactoflora of future host (transplantation principle).
Results: Joint pair cultivation (in vitro on the solid a bit modified
MRS medium in the microaerophilic conditions) of 11 industrial
probiotic lactobacillus strains and 1079 fresh isolated indigenous
lactobacillus strains selected from digestive and vaginal tracts of
humans, white rats and mice has shown that all strains investi-
gated might be divided into three groups: compatible, incompa-
tible and synergenic. Antagonistic relationships were predominant
among probiotic and fresh isolated lactobacillus strains. In these
conditions probiotic strains suppressed the growth and develop-
ment of more than 60% indigenous lactobacillus strains of human
origin. Among probiotic cultures L.acidophilus NK-1 and K3 III
24 (strains used in probiotic food additive ‘‘AciLac’’, Russia)
possessed the most spectrum of antagonistic activities and over-
powered all test lactobacillus strains investigated. Among indi-
genous lactobacillus strains this activity depended on species,
individual peculiarities of strains, host species and anatomical
place of bacterial strain isolation (4). The biocompatibility of
resident lactobacillus strains isolated from feces of rodent females
and their progeny took place in more than 80% pair strain
combinations investigated. Lactobacillus strains isolated from
feces of month old animals belonging to the same brood were
biocompatible in about 75% combination investigated. Intragas-
tric application of incompatible probiotic lactobacilli (one-day,
1.5x1010 cfu) to intact adult conventional white mice was
accompanied (10 hours later) with short time decreasing of host
resident lactobacilli number. Application of incompatible lacto-
bacilli to mice with previously antibiotic eliminated lactoflora was
accompanied by temporary colonization of mouse intestinal tract
with the new lactobacillus strain/ Additional application of the
same animals with compatible homo lactobacillus strain or
especially autostrain resulted in more fast displacing of incompa-
tible bacteria previously colonized colon.
In the process of growing in vitro lactobacilli produced various
metabolites with molecular mass less and more 12000 D (organic
acids, H202, lactocins, lectins, vitamins, peptides, aminoacids and
other including non identified substances). In dependence on
concentration these metabolites could be as bacterium growth
inhibitors or as stimulators of producer and/or other lactobacillus
strains. Some metabolites were more active in conditions of
neutralization of acids (solid MRS medium with 1% chalk) (5).
Conclusion: To receive fast stable positive probiotic effect and to
prevent undesirable aside consequences it is necessary to indivi-
dualize selection of probiotic strains for each recipient using the
widen spectrum of specific in vitro laboratory tests.
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